Wayne, PA, United States
Wayne, PA, United States
SEARCH FILTERS
Time filter
Source Type

News Article | April 21, 2017
Site: www.businesswire.com

ST. PAUL, Minn.--(BUSINESS WIRE)--In 1902, Thomas Edison was still an avid inventor. His ingenuity and scientific pursuits resulted in technologies that would impact the everyday living for millions of people. Also in 1902 was the inception of 3M, which ever since has applied science to life with Edison’s same determination as a way to improve the daily lives of its consumers. 3M today announced that two of its most innovative and advanced technologies have been selected to receive a 2017 Edison Award — a global recognition honoring innovators that create a positive impact in the world. The 3M™ Molecular Detection Assay 2 from 3M Food Safety received a Gold and 3M™ Mobile True Definition Scanner from 3M Oral Care received a Bronze Edison Award in the Diagnostic Tools category. Category finalists were judged by a panel of more than 3,000 senior business executives and academics in the fields of product development, design, engineering, science and medicine. Winners were chosen for their excellence in concept, value, delivery and impact. Gold Award-Winning 3M Molecular Detection Assay 2 The 3M Molecular Detection Assay 2 platform is the next generation of tests for 3M’s previously Edison-awarded 3M™ Molecular Detection System. Powered by Isothermal DNA Amplification and Bioluminescence Detection, the technology makes molecular detection of foodborne pathogens simpler and faster, providing food manufacturers never-before-available speed and ease in identifying Salmonella, Listeria, Listeria monocytogenes, E. coli O157 (including H7) in food or environment-collected samples, and Cronobacter for powdered infant formula. It uses a single assay protocol for all pathogens, enabling batch processing of up to 96 different samples at once and improving efficiency in the laboratory. Enhanced with a proprietary 3M nanotechnology, the test gives processors a streamlined workflow that simplifies their pathogen detection, enabling same- or next-day results and faster, more confident food safety decisions. Comparative research shows that the 3M Molecular Detection Assay 2 - Salmonella, for example, will process a batch of 96 samples 1.7 times faster than the closest competitive technology. “At 3M, we work to enhance food safety by offering transformational technology that protects the health of consumers while optimizing productivity, and protecting the brands of our customers,” said Polly Foss, vice president and general manager for 3M Food Safety. “Therefore, we are especially proud to receive this honor as it showcases our commitment to innovative solutions that bring about safety and quality in our food supply.” Bronze Award-Winning 3M Mobile True Definition Scanner The 3M Mobile True Definition Scanner from 3M Oral Care is a one-of-a-kind tablet-based intraoral scanner. The ergonomic, handheld technology is similar to tablets patients and clinicians use in everyday life, and gives clinicians the freedom to move within their facilities while carrying the scanner with them. It offers more space for the clinician and assistant to maneuver. Also, the device can be placed directly into the hands or lap of a patient for informed discussion and patient communication, providing cutting-edge visualization of the patient’s oral anatomy for a better understanding of treatment. “It is an honor to receive an Edison Award for our innovative approach to oral care and commitment to bringing digital advancement to the industry,” said James Ingebrand, president and general manager for 3M Oral Care. “Positively impacting both the ability of clinicians to provide quality treatment and the oral health of patients is what is most important to the work we are doing at 3M, and we appreciate being recognized for that commitment to the oral care industry.” About the Edison Awards The Edison Awards is a program conducted by Edison Universe, a non-profit 501 (c)(3) organization dedicated to fostering future innovators. The Edison Awards have been recognizing and honoring the best innovations and innovators since 1987. For more information about the Edison Awards, please visit http://www.edisonawards.com. About 3M At 3M, we apply science in collaborative ways to improve lives daily. With $30 billion in sales, our 90,000 employees connect with customers all around the world. Learn more about 3M’s creative solutions to the world’s problems at www.3M.com or on Twitter at @3M or @3MNewsroom.


This report deals with cytogenetics in a broader sense rather than the classical use mainly to describe the chromosome structure and identify abnormalities related to disease. In the age of molecular biology, it is also referred to as molecular cytogenetics. The scope of cytogenetics includes several technologies besides fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and multicolor FISH. Molecular cytogenetics includes application of nanobiotechnology, microarrays, real-time polymerase chain reaction (PCR), in vivo imaging, and single molecule detection. Bioinformatics is described briefly as it plays an important role in analyzing data from many of these technologies. FISH remains the single most important technology in cytogenetics. Several innovations are described of which the most important are single copy FISH, in vivo FISH (imaging of nucleic acids in living cells) and nanotechnology-based FISH. The unique character of peptide nucleic acid (PNA) allows these probes to hybridize to target nucleic acid molecules more rapidly and with higher affinity and specificity compared with DNA probes. PNA-FISH is more suited for rapid diagnosis of infections. RNA-FISH and locked nucleic acids (LNAs), are also described. Microarray/biochip-based technologies for cytogenetics promise to speed up detection of chromosome aberrations now examined by FISH. Other important genomic technologies are whole genome expression array and direct molecular analysis without amplification. Analysis of single-cell gene expression promises a more precise understanding of human disease pathogenesis and has important diagnostic applications. Optical Mapping can survey entire human genomes for insertions/deletions, which account for a significantly greater proportion of genetic variation between closely-related genomes as compared to single nucleotide polymorphisms (SNPs), and are a major cause of gene defects. The report includes summary profiles of 69 companies relevant to cytogenetics along with their 80 collaborations. Companies developing innovative technologies as well as those supplying equipment/services/reagents are identified. The report text is supplemented with 27 Tables and 9 figures. Selected 200 references are included in the bibliography. Key Topics Covered: Executive Summary 1. Introduction 2. Technologies used for cytogenetics 3. Fluorescent In Situ Hybridization 4. Genomic Technologies relevant to Cytogenetics 5. Molecular Imaging & Single Molecular Detection 6. Role of Nanobiotechnology in Cytogenetics 7. Biomarkers and Cytogenetics 8. Applications of Cytogenetics 9. Cancer Cytogenetics 10. Cytogenetics Markets 11. Companies 12. References For more information about this report visit http://www.researchandmarkets.com/research/vzv3hl/cytogenetics Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-2017-cytogenetics-technologies-markets-and-companies-report---projections-to-2026-69-companies-with-80-collaborations---research-and-markets-300455435.html


The present invention relates generally to detection of antibiotic-resistant bacteria in a sample. In particular, the invention provides methods, compositions and kits for detecting and analyzing methicillin-resistant Staphylococcus aureus (MRSA) and other methicillin-resistant bacteria in a sample.


The present invention relates generally to detection of antibiotic-resistant bacteria in a sample. In particular, the invention provides methods, compositions and kits for detecting and analyzing methicillin-resistant Staphylococcus aureus (MRSA) and other methicillin-resistant bacteria in a sample.


The present invention relates generally to detection of antibiotic-resistant bacteria in a sample. In particular, the invention provides methods, compositions and kits for detecting and analyzing methicillin-resistant Staphylococcus aureus (MRSA) and other methicillin-resistant bacteria in a sample.


The present invention relates generally to detection of antibiotic-resistant bacteria in a sample. In particular, the invention provides methods, compositions and kits for detecting and analyzing methicillin-resistant Staphylococcus aureus (MRSA) and other methicillin-resistant bacteria in a sample.


The present invention relates generally to detection of antibiotic-resistant bacteria in a sample. In particular, the invention provides methods, compositions and kits for detecting and analyzing methicillin-resistant Staphylococcus aureus (MRSA) and other methicillin-resistant bacteria in a sample.


Patent
Molecular Detection | Date: 2012-10-11

A method for processing DNA polymerase and/or dNTPs for use in an amplification procedure, includes providing a solution mixture, the solution mixture including a DNA polymerase and/or dNTPs, a buffer solution and at least one stabilizing agent and hydration reducing the solution mixture. The solution mixture is hydration reduced at a temperature between 0 C. and about 100 C.


The present invention relates generally to detection of antibiotic-resistant bacteria in a sample. In particular, the invention provides methods, compositions and kits for detecting and analyzing methicillin-resistant Staphylococcus aureus (MRSA) and other methicillin-resistant bacteria in a sample.


Patent
Molecular Detection | Date: 2013-11-15

Provided herein are methods and compositions involving Polymerase Chain Reaction (PCR).

Loading Molecular Detection collaborators
Loading Molecular Detection collaborators